Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2007-04-03
2010-12-21
Kolker, Daniel E (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S133100, C424S135100, C424S141100, C530S387300, C530S387900, C530S388100
Reexamination Certificate
active
07854931
ABSTRACT:
The present invention is directed to an immunizing composition containing an antigenic product such as a multiple antigen peptide system (MAPS) or a filamentous bacteriophage displaying an AβPP epitope spanning the β-secretase cleavage site of AβPP and a method for inducing an immune response against the β-secretase cleavage site of AβPP using this immunizing composition. The present invention is also directed to antibodies against the β-secretase cleavage site of AβPP and their use in a method for inhibiting the formation of amyloid β.
REFERENCES:
patent: 5229490 (1993-07-01), Tam
patent: 5387742 (1995-02-01), Cordell
patent: 5721130 (1998-02-01), Seubert et al.
patent: 6703015 (2004-03-01), Solomon et al.
patent: 6919075 (2005-07-01), Solomon et al.
patent: 2002/0052311 (2002-05-01), Solomon et al.
patent: 2003/0077252 (2003-04-01), Solomon et al.
patent: 2004/0013647 (2004-01-01), Solomon et al.
patent: 2004/0052766 (2004-03-01), Solomon et al.
patent: 2005/0053575 (2005-03-01), Solomon
patent: 2005/0089510 (2005-04-01), Solomon et al.
patent: 2005/0152878 (2005-07-01), Solomon et al.
patent: 2006/0008458 (2006-01-01), Solomon
patent: 2007/0134247 (2007-06-01), Solomon
patent: 99/27944 (1999-06-01), None
patent: 00/72880 (2000-12-01), None
patent: 0118169 (2001-03-01), None
patent: 01/53457 (2001-07-01), None
patent: 02074243 (2002-09-01), None
patent: 03/000719 (2003-01-01), None
Steinhilb et al. The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem. Feb. 9, 2001;276(6):4476-84. Epub Nov. 17, 2000.
U.S. Appl. No. 11/927,606, filed Oct. 29, 2007.
U.S. Appl. No. 11/929,547, filed Oct. 30, 2007.
Frenkel et al, “Towards Alzheimer's beta-amyloid vaccination,” Biologicals 29(3-4):243-247 (2001).
Frenkel et al, “Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration,” Proc Natl Acad Sci USA 97(21):11455-11459 (2000).
Morgan D. et al., “Abeta peptide vaccination prevents memory loss in ananimal model of Alzheimer's disease”, Nature. (Dec. 28, 2000), vol. 408, pp. 982-985.
Demattos R. et al., “Peripheral anti-Abeta antibody alters CNS and plasma Abeta clearance and decreases brain Abeta burden in a mouse model of Alzheimer's disease”, PNAS. (Jul. 17, 2001), vol. 98, No. 15, pp. 8850-8855.
Arbel, M., 2007. “Immunomodulation of β-secretase activity in cellular and animal models of Alzheimer's disease.” Thesis, section 4.2.5.
Arbel, M., Yacoby, I., Solomon, B., 2005. “Inhibition of amyloid precursor protein processing by β-secretase through site-directed antibodies.” Proc Natl Acad Sci USA 102, 7718-7723.
Arbel-Ornath, M., Becker, M., Rabinovitch-Toidman, P., Gertner, M., Solomon B., 2010. “APPβ-site antibody alleviates Aβ related pathology in Alzheimer's disease mice model.” manuscript accepted for publication.
Arbel, M., Solomon, B., 2007. A Novel Immunotherapy for Alzheimer's Disease: Antibodies against the β-Secretase Cleavage Site of APP. Curr Alzheimer Res. 4, 437-445.
Bayer T.A. and Wirths O. 2010. Intracellular accumulation of amyloid-β—a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Review article in Frontiers in Aging Neuroscience 28: 1-10.
Billings, L.M. et al. 2005. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 45:675-688.
Cataldo, A.M. et al. 1997. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J. Neurosci. 17:6142-6151.
Chang, W.P., Downs, D., Huang, X.P., Da, H., Fung, K.M., Tang, J., 2007. “Amyloid-β reduction by memapsin 2 (beta-secretase) immunization.” Faseb J 21, 3184-3196.
Citron, M., Teplow, D.B., Selkoe, D.J., 1995. “Generation of amyloid β protein from its precursor is sequence specific.” Neuron 14, 661-670.
Hou et al., 2009. Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons, Neuroscience Letters, 462:294-299.
Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., Smith, T.S., Simmons, D.L., Walsh, F.S., Dingwall, C., Christie, G., 1999. “Identification of a novel aspartic protease (Asp 2) as β-secretase.” Mol Cell Neurosci 14, 419-427.
Kinoshita, A., Fukumoto, H., Shah, T., Whelan, C.M., Irizarry, M.C., Hyman, B.T., 2003. “Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.” J Cell Sci 116, 3339-3346.
Kitazume, S., Tachida, Y., Oka, R., Kotani, N., Ogawa, K., Suzuki, M., Dohmae, N., Takio, K., Saido, T.C., Hashimoto, Y., 2003. Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's β-secretase (BACE1). J Biol Chem 278, 14865-14871.
Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T.C., Hashimoto, Y., 2001. Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Proc Natl Acad Sci USA 98, 13554-13559.
Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, Wen H, Chiang HC, Xu G, Koliatsos VE, Borchelt DR, Price DL, Lee HK, Wong PC. 2005. “BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.” J Neurosci. 25, 11693-11709.
Lichtenthaler, S.F., Dominguez, D.I., Westmeyer, G.G., Reiss, K., Haass, C., Saftig, P., De Strooper, B., Seed, B., 2003. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem 278, 48713-48719.
Morgan, D., 2005. “Mechanisms of Aβ plaque clearance following passive Aβ immunization.” Neurodegener Dis 2, 261-266.
Nixon, R. A., Mathews, P. M. & Cataldo, A. M. 2001. The neuronal endosomallysomal system in Alzheimer's disease. J. Alzheimer's Dis. 3, 97-107.
Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF. 2004. “BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease.” Neuron 41, 27-33.
Rakover, I., Arbel, M., Solomon, B., 2007. “Immunotherapy against APP β-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.” Neurodegener Dis 4, 392-402.
Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., Dovey, H.F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S.M., Wang, S., Walker, D., Zhao, J., McConlogue, L., John, V., 1999. “Purification and cloning of amyloid precursor protein β-secretase from human brain.” Nature 402, 537-540.
Soriano, S., Chyung, A.S., Chen, X., Stokin, G.B., Lee, V.M., Koo, E.H., 1999. “Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid β(1-40) and amyloid β(1-42) peptides within secretory and endocytic compartments.” J Biol Chem 274, 32295-32300.
Vassar et al., 1999, β-secretase cleavage of Alzheimer's Amyloid protein by the transmembrane aspartic protease BACE, Science, 286:735-741.
Wilcock, D.M., Rojiani, A., Rosenthal, A., Subbarao, S., Freeman M.J., Gordon, M.N., Morgan, D., 2004. “Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and mi
Browdy and Neimark PLLC
Emch Gregory S
Kolker Daniel E
Ramot At Tel-Aviv University Ltd.
LandOfFree
Immunizing compostion and method for inducing an immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunizing compostion and method for inducing an immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunizing compostion and method for inducing an immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153741